<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment and prognosis of febrile seizures</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment and prognosis of febrile seizures</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Treatment and prognosis of febrile seizures</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John J Millichap, MD, FAAP, FAAN</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas R Nordli, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Dashe, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H762181544"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Febrile seizures are the most common neurologic disorder of infants and young children, occurring in 2 to 4 percent of children younger than five years of age. They are an age-dependent phenomenon with a strong genetic predisposition. While often frightening to parents, caregivers, and witnesses, febrile seizures are a mostly benign occurrence and are associated with a low risk for future epilepsy. Approximately one-third of children will have recurrent febrile seizures during early childhood, and the risk is increased in association with certain clinical features, including young age, low fever, family history of febrile seizures, and abnormal development at the time of first seizure.</p><p>Febrile seizures are described as being simple or complex. Simple febrile seizures are the most common type and are characterized by a single generalized seizure lasting less than 10 to 15 minutes. Complex febrile seizures include those that are focal, prolonged, or recurrent within a 24-hour period. (See  <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">"Clinical features and evaluation of febrile seizures"</a>.)</p><p>While simple febrile seizures have typically spontaneously resolved by the time the child is evaluated and do not need to be treated, prolonged seizures may require abortive treatment with benzodiazepines in the ambulance or in the emergency department. Prophylactic antiseizure medications can decrease the risk of recurrent febrile seizures, but given the benign nature of most seizures, the risks of side effects generally outweigh the benefits.</p><p>This topic will review the treatment and prognosis of febrile seizures, including febrile status epilepticus. Management of afebrile seizures and epilepsy in infants and children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6203.html" rel="external">"Seizures and epilepsy in children: Initial treatment and monitoring"</a>.)</p><p class="headingAnchor" id="H762182288"><span class="h1">INITIAL ASSESSMENT</span><span class="headingEndMark"> — </span>The initial evaluation of children with seizure in the setting of fever must distinguish febrile seizure from alternative and more serious etiologies such as central nervous system infection. This can be accomplished with a thorough history and physical examination in most cases, along with neuroimaging and lumbar puncture in selected circumstances. Children with focal or prolonged febrile seizures may require more extensive evaluation than those with simple febrile seizures, particularly at the time of the first seizure. Therapies discussed below assume that such etiologies have been ruled out and that the diagnosis of febrile seizure has been established. (See  <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">"Clinical features and evaluation of febrile seizures"</a>.)</p><p class="headingAnchor" id="H762181597"><span class="h1">ACUTE MANAGEMENT</span></p><p class="headingAnchor" id="H762182888"><span class="h2">Emergency rescue therapy</span><span class="headingEndMark"> — </span>The majority of febrile seizures have ended spontaneously by the time the child is first evaluated, and the child is rapidly returning to a normal baseline. In such cases, active treatment with benzodiazepines is not necessary. Fever should be treated symptomatically with antipyretics.</p><p>As with afebrile seizures, febrile seizures that continue for more than five minutes should be treated. Intravenous benzodiazepines (<a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> 0.1 to 0.2 mg/kg or <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">lorazepam</a> 0.05 to 0.1 mg/kg) are effective in aborting seizure in many cases. If the seizure persists, an additional dose may be given. The child's respiratory and circulatory status should be monitored carefully and an advanced airway intervention (eg, bag-mask ventilation, laryngeal mask airway, definitive artificial airway) undertaken if the ventilatory status becomes inadequate. (See  <a class="medical medical_review" href="/z/d/html/6383.html" rel="external">"Basic airway management in children"</a> and  <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">"Technique of emergency endotracheal intubation in children"</a>.)</p><p>The efficacy and safety of intravenous benzodiazepines as first-line agents for the treatment of seizures in children has been demonstrated in several randomized trials, primarily in children with afebrile seizures or status epilepticus. A 2018 meta-analysis concluded that intravenous <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">lorazepam</a> was as effective as intravenous <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> and that both were associated with similar rates of respiratory depression [<a href="#rid1">1</a>]. In a randomized trial of 273 children with status epilepticus, intravenous lorazepam and intravenous diazepam had similar efficacy, but lorazepam-treated children were more likely to be sedated (67 versus 50 percent) [<a href="#rid2">2</a>]. Rates of intubation were similar (16 to 17 percent). (See  <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">"Management of convulsive status epilepticus in children", section on 'Benzodiazepine efficacy and pharmacokinetics'</a>.)</p><p>When intravenous access is unavailable or cannot be achieved, buccal <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">midazolam</a> is an effective alternative [<a href="#rid1">1</a>]; a typical dose is 0.2 mg/kg, maximum dose 10 mg. Intranasal <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">lorazepam</a> is also an option. A systematic review and meta-analysis of 18 trials including 2199 children concluded that buccal or intranasal antiseizure medications were as effective as intravenous antiseizure medications in treating status epilepticus, but there was only low-quality evidence comparing buccal midazolam with rectal <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> [<a href="#rid1">1</a>]. Respiratory complications requiring assisted ventilation are similar, regardless of administration route. (See  <a class="medical medical_review" href="/z/d/html/101361.html" rel="external">"Seizures and epilepsy in children: Refractory seizures", section on 'Home rescue therapy (transmucosal antiseizure medications)'</a>.)</p><p class="headingAnchor" id="H864054186"><span class="h2">Febrile status epilepticus</span><span class="headingEndMark"> — </span>Patients with prolonged or repetitive seizures despite initial benzodiazepine administration (ie, febrile status epilepticus) should be treated promptly with additional antiseizure medications, as are other patients with status epilepticus. The most commonly used drug in this setting is <a class="drug drug_pediatric" data-topicid="13327" href="/z/d/drug information/13327.html" rel="external">fosphenytoin</a> (20 mg <a class="drug drug_pediatric" data-topicid="12702" href="/z/d/drug information/12702.html" rel="external">phenytoin</a> equivalents [PE]/kg intravenously). Efforts should be made to lower fever with antipyretics and a cooling blanket. The management of status epilepticus in children is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">"Management of convulsive status epilepticus in children"</a> and  <a class="medical medical_review" href="/z/d/html/5989.html" rel="external">"Fever in infants and children: Pathophysiology and management", section on 'Management of fever'</a>.)</p><p>Febrile status epilepticus rarely stops spontaneously and often requires more than one medication to control [<a href="#rid3">3,4</a>]. It is more common in young children and is focal in two-thirds of cases [<a href="#rid3">3,5</a>]. In a prospective cohort study of 119 children presenting with prolonged febrile seizures (&gt;30 minutes), 70 percent of children required more than one antiseizure medication, and delays in antiseizure medication administration were associated with longer seizure duration [<a href="#rid3">3</a>]. Important clinical clues that a seizure has ended include the presence of closed eyes and a deep breath. Children with persistently open and deviated eyes may still be seizing, even if convulsive motor activity has stopped. (See  <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">"Clinical features and evaluation of febrile seizures", section on 'Febrile status epilepticus'</a>.)</p><p class="headingAnchor" id="H750680558"><span class="h2">Prehospital treatment</span><span class="headingEndMark"> — </span>Treatment of prolonged seizures by paramedics with either intramuscular <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">midazolam</a> or intravenous <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">lorazepam</a> appears to be safe and effective in children with status epilepticus [<a href="#rid6">6</a>], and limited data support out-of-hospital treatment for prolonged febrile seizures as well [<a href="#rid5">5</a>]. The ability of emergency medical services (EMS) to administer antiseizure medications varies by region, however. (See  <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">"Management of convulsive status epilepticus in children", section on 'Prehospital treatment'</a>.)</p><p>In a prospective study of children presenting to the emergency department with prolonged febrile seizure (&gt;15 minutes), 11 percent of those receiving rectal <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> in the ambulance responded, compared with 58 percent of patients treated with intravenous diazepam [<a href="#rid5">5</a>]. In a larger prospective study, earlier onset of treatment was associated with shorter total seizure duration of febrile status epilepticus and better outcomes [<a href="#rid3">3</a>]. Similarly in the United Kingdom, an epidemiological study strongly supported prehospital treatment with buccal <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">midazolam</a> as a widely used but unlicensed option in the community [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H762183879"><span class="h1">DISCHARGE DISPOSITION</span><span class="headingEndMark"> — </span>Most children with simple febrile seizures do not require hospital admission and can be discharged safely to home once they have returned to a normal baseline and parents and caregivers have been educated about the risk of recurrent febrile seizures. (See <a class="local">'Recurrent febrile seizures'</a> below.)</p><p>Children with focal or prolonged seizures may require a more extended period of observation, particularly if there is delayed recovery to baseline or postictal focality. The normal duration of the postictal phase is not well defined, but available studies suggest that return to cognitive baseline typically occurs within five minutes [<a href="#rid8">8</a>]. Failure to return to cognitive baseline within five minutes or the presence of focal postictal weakness (Todd paralysis) would constitute delayed recovery. A Todd paralysis may last up to 24 hours.</p><p>In addition, children with focal or prolonged seizures are at higher risk of having multiple seizures within the index illness. In a retrospective study of 228 presenting to an emergency department with febrile seizure, the cumulative probability of early recurrence was 9 percent within 6 hours, 13 percent within 12 hours, and 16 percent within 24 hours [<a href="#rid9">9</a>]. Ninety percent of recurrences occurred within the first 24 hours. Risk factors for early recurrence were focal seizure and prolonged seizure (&gt;15 minutes).</p><p>Additional factors to consider when deciding whether to admit a child include the confidence with which outpatient follow-up can be arranged (for focal or prolonged seizures), comfort level of the parents or caregivers, and severity of the underlying febrile illness (eg, hydration status, ability to take oral fluids).</p><p class="headingAnchor" id="H762183546"><span class="h1">RECURRENT FEBRILE SEIZURES</span><span class="headingEndMark"> — </span>Children with febrile seizures are at risk for developing recurrent febrile seizures with future illnesses during early childhood.</p><p class="headingAnchor" id="H864056578"><span class="h2">Risk factors for recurrence</span><span class="headingEndMark"> — </span>The overall recurrence rate is approximately 30 to 35 percent [<a href="#rid10">10,11</a>]. However, the values vary with age, from as high as 50 to 65 percent in children who are younger than one year of age at the time of the first seizure, to as low as 20 percent in older children [<a href="#rid12">12</a>]. A major factor influencing the recurrence rate is the age of the infant at the time of the first seizure.</p><p>A prospective cohort study of 428 children with a first febrile seizure defined other features and factors influencing recurrences [<a href="#rid10">10</a>]. Approximately one-third of the children had at least one recurrence, 17 percent had one recurrence, 9 percent had two recurrences, and approximately 6 percent had three or more recurrences. The majority of recurrences (50 to 75 percent) took place within one year of the initial seizure, and almost all occurred within two years [<a href="#rid13">13</a>]. Four factors in the prospective cohort study increased the recurrence risk [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Young age at onset</p><p class="bulletIndent1"><span class="glyph">●</span>History of febrile seizures in a first-degree relative</p><p class="bulletIndent1"><span class="glyph">●</span>Low degree of fever while in the emergency department</p><p class="bulletIndent1"><span class="glyph">●</span>Brief duration between the onset of fever and the initial seizure</p><p></p><p>Children who had all four factors were much more likely to have a recurrent febrile seizure than were those with none (≥70 versus ≤20 percent). Complex features were not associated with the risk of recurrence. These findings were confirmed in another prospective study [<a href="#rid14">14</a>].</p><p>Other factors identified in different studies have been abnormal development before the first febrile seizure, a history of afebrile seizures in parents and siblings, recurrence of seizures within the same illness, and the number of subsequent febrile illnesses [<a href="#rid11">11,13-16</a>]. Among children who have had one recurrence, younger age at the time of the first recurrence and a family history of epilepsy are predictors of subsequent recurrences [<a href="#rid10">10,14</a>]. Another risk factor is an unprovoked seizure after a febrile seizure; such children are at substantial risk for further seizures with fever (rate ratio 3.47 after adjusting for the above risk factors, p = 0.0015) [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H864054995"><span class="h2">Provision of home benzodiazepines</span><span class="headingEndMark"> — </span>In children with a history of prolonged febrile seizure, including febrile status epilepticus (FSE), <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> rectal gel (0.5 mg/kg) can be administered by parents or caregivers at home if the episode lasts longer than five minutes [<a href="#rid18">18</a>]. Parents and caregivers can be taught to safely give the medication at home, and one dose administered rectally will not lead to respiratory depression.</p><p>Where available, <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">midazolam</a> nasal spray is an alternative to rectal <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> for home use. A comparison of midazolam nasal spray and rectal diazepam solution for residential treatment of seizure exacerbations found that midazolam was equal in efficacy to diazepam, and drowsiness occurred in more than 50 percent of administrations for both drugs [<a href="#rid19">19</a>]. The majority of patients and caregivers preferred the nasal spray to rectal formulations.</p><p>Factors helpful in predicting future prolonged febrile seizures are focality and history of prolonged febrile seizure, including FSE [<a href="#rid20">20</a>]. There appears to be a strong correlation between focality and prolonged duration of both first and recurrent febrile seizures [<a href="#rid18">18</a>]. In children with recurrent febrile seizures, those with long duration (defined as lasting longer than 10 minutes) tend to have similar features in repeat episodes. Similarly, children who have multiple risk factors for recurrent febrile seizures (focal onset, multiple seizures during the episode) and have a prolonged febrile seizure often have prolonged recurrent febrile seizures [<a href="#rid10">10</a>]. This is a group of children for whom rectal therapy at the time of occurrence should be strongly considered.</p><p class="headingAnchor" id="H762181856"><span class="h2">Role of preventive therapy</span><span class="headingEndMark"> — </span>Prophylactic antiseizure medications can decrease the risk of recurrent febrile seizures, but given the benign nature of most seizures, the risks of side effects generally outweigh the benefits [<a href="#rid16">16,21,22</a>]. Use of antipyretics at the first sign of fever does not prevent recurrent febrile seizures.</p><p class="headingAnchor" id="H762181862"><span class="h3">Antiseizure therapy</span><span class="headingEndMark"> — </span>Children with febrile seizures are at increased risk for recurrent febrile seizures as well as the development of afebrile seizures, suggesting a role for prophylactic treatment with chronic antiseizure medications. However, given the benign nature of recurrent febrile seizures, there is general consensus that risks of antiseizure medication treatment outweigh potential benefits for most patients [<a href="#rid21">21,23</a>].</p><p>The effectiveness of antiseizure medications was evaluated in a meta-analysis of studies for the prevention of recurrent febrile seizures [<a href="#rid24">24</a>]. While treatment with <a class="drug drug_pediatric" data-topicid="12698" href="/z/d/drug information/12698.html" rel="external">phenobarbital</a> or intermittent oral or rectal <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> was associated with reduced risk of recurrent seizures in the short term (six months to two years), this was also associated with a risk of adverse effects in up to 30 percent of children [<a href="#rid24">24-27</a>]. The use of chronic antiseizure medications or the prevention of recurrent febrile seizures is not associated with a reduced risk of epilepsy [<a href="#rid16">16,21</a>].</p><p>A clinical practice guideline developed by the Committee on Quality Improvement, Subcommittee on Febrile Seizures of the American Academy of Pediatrics concludes that neither continuous nor intermittent anticonvulsive therapy is recommended for children with one or more simple febrile seizures, based on the risks and benefits of effective therapies [<a href="#rid21">21</a>]. The guideline also recognizes that recurrent episodes of febrile seizures can create anxiety in some parents, caregivers, and affected children and as such, appropriate educational and emotional support should be provided.</p><p>This guideline does not address children with complex febrile seizures in whom the risk of future afebrile seizures is higher than in those with simple febrile seizures. In some children, a febrile seizure may represent the first presentation of epilepsy. Treatment decisions in such cases should be individualized based upon underlying risk factors, but there is no evidence that supports treatment in any one subset of patients. However, careful clinical history and review of the electroencephalogram (EEG) in cases of complex febrile seizures or febrile status epilepticus may reveal characteristics of an underlying epilepsy syndrome or risk factors for later development of temporal lobe epilepsy, such as acute focal slowing on EEG or subsequent mesial temporal sclerosis on magnetic resonance imaging (MRI) [<a href="#rid28">28,29</a>]. The benefits of antiseizure medication therapy may outweigh risks in such cases, particularly if caregiver concern about recurrent seizures is high and the risks of antiseizure medication therapy are carefully considered.</p><p class="headingAnchor" id="H762181868"><span class="h3">Antipyretics</span><span class="headingEndMark"> — </span>For children who have had febrile seizures, treatment with antipyretics at the time of a febrile illness may allay discomfort and reduce the recurrence of febrile seizures during the same fever episode [<a href="#rid30">30</a>], but it does not appear to affect the recurrence rate of febrile seizures in subsequent fever episodes [<a href="#rid21">21,24,27</a>].</p><p>An open-label trial from Japan found that <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">acetaminophen</a> reduced febrile seizure recurrence during the same fever episode [<a href="#rid30">30</a>]. The trial enrolled over 400 children who presented to the hospital with febrile seizures and randomly assigned them to acetaminophen (10 mg/kg by suppository every six hours until 24 hours after febrile seizure onset if temperature remained &gt;38.0° C) or to no antipyretic treatment. The rate of febrile seizure recurrence during the same fever episode was lower in the group assigned to rectal acetaminophen compared with the group assigned to no antipyretics (9 versus 24 percent). There were no serious adverse events related to acetaminophen.</p><p>However, antipyretic treatment does not appear to affect the recurrence rate of febrile seizures in subsequent fever episodes. A 2013 systematic review and meta-analysis that included three randomized controlled trials in 540 patients with febrile seizure also concluded that antipyretics (<a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">acetaminophen</a>, <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">ibuprofen</a>, or <a class="drug drug_pediatric" data-topicid="13226" href="/z/d/drug information/13226.html" rel="external">diclofenac</a>) were ineffective in reducing the rate of recurrent febrile seizures, compared with placebo [<a href="#rid31">31</a>]. The risk of recurrent febrile seizure was 23 percent in the antipyretics group and 24 percent in the placebo group during a one to two-year follow-up period.</p><p>There are several potential physiologic reasons why antipyretics may not prevent febrile seizures. Antipyretics facilitate heat loss but do not retard temperature elevation or lower the threshold convulsive temperature during the initial stage of fever that triggers a seizure [<a href="#rid32">32</a>]. Heat production is not inhibited by antipyretics, but heat dissipation is augmented by increased peripheral blood flow and sweating [<a href="#rid33">33</a>].</p><p>Both <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">acetaminophen</a> and barbiturates cause a fall in body temperature by depression of the central temperature regulatory mechanism. <a class="drug drug_pediatric" data-topicid="12698" href="/z/d/drug information/12698.html" rel="external">Phenobarbital</a> inhibits heat production during the pyrogenic stage of the fever, whereas acetaminophen facilitates heat loss at the height of the fever or during its defervescence. The mechanism whereby phenobarbital reduces febrile seizure recurrence may be related to both an antipyretic and anticonvulsant effect [<a href="#rid32">32</a>].</p><p>The role of antipyretics in the management of fever in children is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5989.html" rel="external">"Fever in infants and children: Pathophysiology and management", section on 'Management of fever'</a>.)</p><p class="headingAnchor" id="H750680570"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis for children with febrile seizures is favorable. While early reports had suggested that febrile seizures were associated with an increased risk of sudden death, the results from a large population-based study indicate that the small excess in mortality among children with febrile seizures is restricted to those with complex febrile seizures [<a href="#rid34">34</a>]. Furthermore, the increased risk in those patients is explained, at least in part, by preexisting neurologic abnormalities and subsequent epilepsy. In six cases of sudden unexplained death in toddlers with febrile seizures, hippocampal abnormalities were identified in one of three with available autopsy [<a href="#rid35">35</a>]. Inheritance was autosomal dominant. The interval from the last febrile seizure to death ranged from three weeks to six months.</p><p class="headingAnchor" id="H750680582"><span class="h2">Neurologic outcomes</span><span class="headingEndMark"> — </span>Neurologic sequelae, including new neurologic deficits, intellectual impairment, and behavioral disorder, are rare following febrile seizures. In a case-control study in which 159 children with febrile seizures were compared with 142 controls, performance on measures of cognition, motor ability, and adaptive behavior were similar at one month after a first febrile seizure and one year later [<a href="#rid36">36</a>].</p><p>Most reports documenting neurologic complications have been anecdotal and derived from biased populations consisting of children assessed in hospitals or clinics; in some cases, they may reflect preexisting abnormalities. When new deficits were reported, they occurred only after complex or prolonged febrile seizures. In a small study, face recognition memory was impaired after prolonged febrile seizures, and the deficit was linked to the size of the hippocampi when tested one year later [<a href="#rid37">37</a>].</p><p>In general, population-based studies do not corroborate anecdotal reports of neurologic complications. In the National Collaborative Perinatal Project (NCPP), approximately 5 percent of children had febrile seizures lasting longer than 30 minutes. None of these children sustained permanent motor deficits and none had impaired mental development unless they developed afebrile seizures [<a href="#rid15">15</a>]. Similar findings were noted in a population-based study of 381 children with febrile convulsions in the United Kingdom [<a href="#rid38">38</a>]. The children were assessed when they were 10 years old, and children who had neurologic and developmental problems prior to the first febrile seizure were excluded. No difference was found in measurements of academic progress in children with febrile seizures, whether simple, complex, or recurrent, compared with a controlled cohort. There was also no difference in behavior between the two groups. Finally, among 18,000 Danish conscripts aged 18 to 20 years old, there was no association found between febrile seizures and cognitive function [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H750680594"><span class="h2">Subsequent epilepsy</span><span class="headingEndMark"> — </span>Epilepsy occurs more frequently in children who have had febrile seizures than in the general population. In a normal child with a simple febrile seizure, the risk is approximately 1 to 2 percent, only slightly above that of the general population [<a href="#rid40">40</a>]. For children with complex febrile seizures, an abnormal developmental history, or a family history of epilepsy, the risk is closer to 5 to 10 percent.</p><p>Epidemiologic studies have identified risk factors for epilepsy among children with febrile seizures:</p><p class="bulletIndent1"><span class="glyph">●</span>In the NCPP, children with abnormal neurologic development and whose first seizure was complex (focal, multiple, or longer than 15 minutes) had a 9.2 percent incidence of afebrile seizures by seven years of age, a risk 18 times higher than that in children with no history of febrile seizures (0.5 percent) and more than eight times higher than that in normal children with a noncomplex first febrile seizure (1.1 percent) [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In Rochester, Minnesota, 687 children with a history of febrile seizures were observed into adulthood [<a href="#rid41">41</a>]. Three risk factors for developing epilepsy were identified: focal seizures, prolonged seizures, and repeated episodes within 24 hours during the same illness. The risk of developing epilepsy was 2.4, 6 to 8, 17 to 22, and 49 percent in children with no, one, two, or three of these risk factors, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A population-based study in Denmark also followed children with febrile seizures into adulthood [<a href="#rid42">42</a>]. The cumulative incidence of epilepsy was 6.9 percent at 23 years, and the relative risk associated with febrile seizures was 5.4. The risk of epilepsy was higher in those with a family history of epilepsy, cerebral palsy, or low Apgar scores at five minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long-term risk of developing epilepsy in a median 21-year follow-up UK study of 181 infants with a first febrile seizure was 6 percent [<a href="#rid43">43</a>]. The risk of developing epilepsy decreased with time.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another cohort study of 181 children with febrile seizure found that the risk of epilepsy was highest in the first five years and appeared to decrease over time [<a href="#rid43">43</a>]. Overall, individuals aged 15 to 19 years with a history of febrile seizure appeared to have a similar risk of epilepsy compared with controls; however, subgroups of children with febrile seizures who might be at higher risk of epilepsy were not compared.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective study of 501 children with a first febrile seizure found a 5.4 percent risk of occurrence of epilepsy during a 30-month follow-up period. Significant prognostic markers for subsequent epilepsy included a family history of epilepsy (especially maternal), complex febrile seizure, focal febrile seizure, Todd's paresis, short fever duration before the seizure, late onset of febrile seizure (&gt;3 years old), and multiple febrile seizure recurrences. Multiple febrile seizures increased the risk of epilepsy 10 times [<a href="#rid44">44</a>].</p><p></p><p class="headingAnchor" id="H750680600"><span class="h3">Electroencephalogram and risk of epilepsy</span><span class="headingEndMark"> — </span>While electroencephalogram (EEG) is not useful in determining the risk of recurrent febrile seizures, it is often performed in the outpatient setting to identify children at increased risk for future epilepsy, in combination with other risk factors.</p><p>The evidence to support the utility of EEG in this setting is mixed, however. In one small study, 25 percent of children (9 of 36) with epileptiform discharges on EEG after febrile seizure developed epilepsy, compared with 2 percent of controls with a normal EEG [<a href="#rid45">45</a>]. The rate of recurrent febrile seizures was similar (33 and 26 percent, respectively). In a larger study that included 154 children with a first complex febrile seizure who underwent EEG, 13 percent of children developed epilepsy with a minimum of two years of follow up [<a href="#rid46">46</a>]. Epileptiform EEGs were noted in 20 percent of those who developed epilepsy and 13 percent of those who did not, resulting in a positive predictive value of only 15 percent. In a later report of 243 children, the presence of interictal epileptiform discharges on EEG following one or more episodes of complex febrile seizures was associated with an increased risk of future epilepsy (odds ratio 3.7, 95% CI 1.37-10.43) [<a href="#rid47">47</a>]. As in the earlier study [<a href="#rid46">46</a>], interictal epileptiform discharges on EEG were noted in 12 of 60 patients (20 percent) of those who developed epilepsy and 23 of 183 (13 percent) of those who did not, giving the same positive predictive value of 15 percent.</p><p>If the decision is made to obtain an EEG, the optimal timing is also uncertain. Abnormalities are more likely to be found when the test is performed shortly after the seizure and when convulsions are of long duration and have focal features. Transient slow wave abnormality up to 10 days after recovery from a febrile seizure is reported in 50 percent of patients [<a href="#rid48">48</a>]. Multiple seizures within 24 hours are predictive of abnormal EEG, and abnormalities are more common in children with complex than simple febrile seizures (43 versus 28 percent) [<a href="#rid49">49</a>]. Some studies suggest that certain abnormal EEG findings may be more strongly associated with the risk of epilepsy than others, but the EEG alone should not be used as a basis for treatment decisions [<a href="#rid50">50</a>].</p><p>Focal EEG slowing or attenuation on an EEG obtained within 72 hours of febrile status epilepticus is a potential biomarker for later development of epilepsy, and such changes are highly associated with MRI evidence of acute hippocampal injury [<a href="#rid28">28</a>]. (See <a class="local">'Febrile status epilepticus'</a> below.)</p><p class="headingAnchor" id="H750680606"><span class="h3">Subsequent temporal lobe epilepsy</span><span class="headingEndMark"> — </span>Although a variety of seizure types follow febrile seizures, whether prolonged febrile seizures lead to the development of temporal lobe epilepsy is controversial. Reports of patients with refractory temporal lobe epilepsy considered for surgery often find an association with febrile convulsions in infancy, particularly prolonged seizures [<a href="#rid51">51</a>]. In addition, studies assessing hippocampal volume in adults with epilepsy have found an association between a smaller hippocampus and a history of febrile seizures [<a href="#rid52">52,53</a>]. Data are conflicting as to whether a correlation exists between the duration of epilepsy and a reduction in hippocampal volume [<a href="#rid54">54</a>]. Hippocampal abnormalities have also been associated with familial febrile seizures [<a href="#rid55">55</a>].</p><p>The possibility of hippocampal injury induced by febrile seizures was assessed by MRI in infants who had had complex febrile seizures [<a href="#rid56">56</a>]. Abnormalities were found in the children with focal and prolonged complex febrile seizures but not in those with generalized febrile seizures. In a few children who had significantly longer seizures, MRI suggested acute edema of the hippocampus, a finding noted in other case series as well [<a href="#rid57">57,58</a>]. Follow-up imaging studies in these children may show hippocampal atrophy or abnormal apparent diffusion coefficient measurements. Another study found that hippocampal atrophy and other MRI characteristics of hippocampal sclerosis were more common in adults with a history of febrile seizures in childhood than those without [<a href="#rid59">59</a>]. Although these observations suggest acute injury to the hippocampus during a febrile seizure, the possibility of preexisting lesions leading to susceptibility to injury is not excluded.</p><p>Studies based mainly upon imaging results and patients being considered for epilepsy surgery suggest an association between febrile seizures and temporal lobe epilepsy. Some clinical studies reached a similar conclusion. In one, patients presenting to an epilepsy clinic because of a previous diagnosis of epilepsy or recent onset of seizures were prospectively questioned about febrile seizures and their characteristics [<a href="#rid60">60</a>]. Febrile seizures were reported by 13.2 percent of the patients. Temporal lobe epilepsy was more likely to be preceded by febrile convulsions than by other types of epilepsy (25.2 versus 5.6 percent, respectively). Prolonged duration was the most common feature of the complex febrile seizure associated with temporal lobe epilepsy, although patients with generalized epilepsy were more likely to have had simple febrile seizures.</p><p>However, carefully performed community-based epidemiologic studies have not been able to confirm this association. In one, the characteristics of epilepsy were evaluated in 524 children who were one year of age or older at the onset of epilepsy [<a href="#rid51">51</a>]. Febrile seizures were present in 14 percent of the patients. Complex febrile seizures were associated with a younger age at onset of the epilepsy, but there was no specific association with localization-related forms of epilepsy. No evidence that focal or prolonged febrile seizures were associated with temporal lobe epilepsy was found; three children had hippocampal atrophy demonstrated on their initial MRI, but none had a history of febrile seizures.</p><p>In summary, febrile seizures do not appear to cause temporal lobe epilepsy. The association may represent an inherent susceptibility in some children who are predisposed to prolonged febrile seizures and epilepsy simultaneously.</p><p class="headingAnchor" id="H750680612"><span class="h2">Febrile status epilepticus</span><span class="headingEndMark"> — </span>Febrile status epilepticus (FSE) is a subset of complex febrile seizures, and as such is associated with an increased risk of recurrent febrile seizures, as well as future afebrile seizures. However, the magnitude of the elevation in risk is not well-defined.</p><p>Clinical follow–up of a large prospective cohort of children with febrile status epilepticus (FEBSTAT) is in progress [<a href="#rid4">4</a>]. Children with febrile status epilepticus are more likely to have hippocampal imaging abnormalities at the time of presentation compared with those with simple febrile seizures, including abnormal hippocampal T2 hyperintensity in 11.5 percent and developmental abnormalities of the hippocampus in 10.5 percent [<a href="#rid4">4,29</a>]. The majority of children with abnormal hippocampal T2 hyperintensity at baseline had evidence of decreased hippocampal volume one year later, but the implications of this finding in terms of long-term seizure risk are not yet known [<a href="#rid61">61</a>]. Compared with children with a first simple febrile seizure, children with FSE are also at an increased risk for subsequent FSE, particularly those with a baseline MRI abnormality [<a href="#rid20">20</a>].</p><p>Another study followed 44 children with FSE, most of whom were followed prospectively [<a href="#rid62">62</a>]. After a mean follow-up of 28 months, the risk of recurrent seizures (febrile and afebrile) was increased only in those who had prior neurologic abnormalities. This finding is similar to that seen in patients with febrile seizures without status. Other case series have found that EEG studies, performed within one week after status, show focal slowing in one-third [<a href="#rid63">63</a>], a finding that has been associated with a higher risk of epilepsy in some studies. (See <a class="local">'Electroencephalogram and risk of epilepsy'</a> above.)</p><p class="headingAnchor" id="H1498461924"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113981.html" rel="external">"Society guideline links: Seizures and epilepsy in children"</a>.)</p><p class="headingAnchor" id="H750680642"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/16118.html" rel="external">"Patient education: Febrile seizures in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/1208.html" rel="external">"Patient education: Febrile seizures (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H750680648"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Description</strong> – Febrile seizures occur in children with fever, usually in the setting of systemic bacterial or viral infection. Affected patients are typically between the ages of six months and five years of age and do not have epilepsy, central nervous system infection or inflammation, or other triggers for seizures. (See  <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">"Clinical features and evaluation of febrile seizures", section on 'Definitions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation</strong> – The initial evaluation must distinguish febrile seizure from alternative and more serious etiologies such as central nervous system infection. In most cases, this can be accomplished with a thorough history and physical examination, as discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">"Clinical features and evaluation of febrile seizures", section on 'Diagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute management </strong>–<strong> </strong>Fever should be treated symptomatically with antipyretics. (See <a class="local">'Acute management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Seizure ended</strong> – The majority of febrile seizures have ended spontaneously by the time the child is first evaluated, and the child is rapidly returning to a normal baseline. In such cases, active treatment with benzodiazepines is not necessary. (See <a class="local">'Emergency rescue therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Seizure prolonged or ongoing </strong>– In children with febrile seizures that continue for more than five minutes, we recommend treatment with intravenous (IV) benzodiazepines (<a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> 0.1 to 0.2 mg/kg or <a class="drug drug_pediatric" data-topicid="12565" href="/z/d/drug information/12565.html" rel="external">lorazepam</a> 0.05 to 0.1 mg/kg) (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). Buccal <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">midazolam</a> (0.2 mg/kg, maximum 10 mg) is an alternative when IV access is unavailable. Patients with continued seizures despite initial benzodiazepine administration (ie, febrile status epilepticus) should be treated promptly with additional antiseizure medications, as are other patients with status epilepticus. (See <a class="local">'Emergency rescue therapy'</a> above and <a class="local">'Febrile status epilepticus'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Disposition</strong> – Most children with simple febrile seizures do not require hospital admission and can be discharged safely to home once they have returned to a normal baseline and parents and caregivers have been educated about the risk of recurrent febrile seizures. Children with focal or prolonged seizures may require a more extended period of observation, particularly if there is delayed recovery to baseline or focal postictal weakness. (See <a class="local">'Discharge disposition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrent febrile seizures</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Risk factors</strong> – Children with febrile seizures are at risk for recurrent febrile seizures, particularly if they have a young age of onset, a family history of febrile seizures, brief latency between onset of fever and seizures, and a relatively low fever. (See <a class="local">'Risk factors for recurrence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Home benzodiazepines</strong> – In children with a history of prolonged febrile seizure, benzodiazepines (eg, <a class="drug drug_pediatric" data-topicid="13223" href="/z/d/drug information/13223.html" rel="external">diazepam</a> rectal gel 0.5 mg/kg) can be administered at home by parents or caregivers if the seizure lasts longer than five minutes. (See <a class="local">'Provision of home benzodiazepines'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Limited role of antiseizure prophylaxis</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>For simple febrile seizures</strong> – We suggest <strong>not</strong> treating patients with simple febrile seizures with antiseizure medication therapy (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). While antiseizure medications may decrease the risk of recurrent febrile seizures, the prevention of febrile seizures is generally not considered worth the potential adverse effects of treatment. The available evidence suggests that the use of chronic antiseizure medications does <strong>not</strong> reduce the risk of epilepsy. (See <a class="local">'Role of preventive therapy'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>For complex febrile seizures</strong> – The use of antiseizure medication prophylaxis in children with complex febrile seizures is individualized based upon underlying risk factors. (See <a class="local">'Antiseizure therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of epilepsy</strong> – Epilepsy occurs more frequently in children who have had febrile seizures than in the general population. In a normal child with a simple febrile seizure, the risk is only slightly above that of the general population. Children with complex febrile seizures, an abnormal developmental history, or a family history of epilepsy have an increased risk. (See <a class="local">'Subsequent epilepsy'</a> above.)</p><p></p><p class="headingAnchor" id="H3115079272"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges J Gordon Millichap, MD, FRCP, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">McTague A, Martland T, Appleton R. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2018; 1:CD001905.</a></li><li><a class="nounderline abstract_t">Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA 2014; 311:1652.</a></li><li><a class="nounderline abstract_t">Seinfeld S, Shinnar S, Sun S, et al. Emergency management of febrile status epilepticus: results of the FEBSTAT study. Epilepsia 2014; 55:388.</a></li><li><a class="nounderline abstract_t">Shinnar S, Hesdorffer DC, Nordli DR Jr, et al. Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008; 71:170.</a></li><li><a class="nounderline abstract_t">Bassan H, Barzilay M, Shinnar S, et al. Prolonged febrile seizures, clinical characteristics, and acute management. Epilepsia 2013; 54:1092.</a></li><li><a class="nounderline abstract_t">Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366:591.</a></li><li><a class="nounderline abstract_t">Neville BG, Chin RF, Scott RC. Childhood convulsive status epilepticus: epidemiology, management and outcome. Acta Neurol Scand Suppl 2007; 186:21.</a></li><li><a class="nounderline abstract_t">Fisher RS, Engel JJ Jr. Definition of the postictal state: when does it start and end? Epilepsy Behav 2010; 19:100.</a></li><li><a class="nounderline abstract_t">Jeong JH, Lee JH, Kim K, et al. Rate of and risk factors for early recurrence in patients with febrile seizures. Pediatr Emerg Care 2014; 30:540.</a></li><li><a class="nounderline abstract_t">Berg AT, Shinnar S, Darefsky AS, et al. Predictors of recurrent febrile seizures. A prospective cohort study. Arch Pediatr Adolesc Med 1997; 151:371.</a></li><li><a class="nounderline abstract_t">Offringa M, Bossuyt PM, Lubsen J, et al. Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J Pediatr 1994; 124:574.</a></li><li><a class="nounderline abstract_t">Frantzen E, Lennox-Buchthal M, Nygaard A. Longitudinal EEG and clinical study of children with febrile convulsions. Electroencephalogr Clin Neurophysiol 1968; 24:197.</a></li><li><a class="nounderline abstract_t">Berg AT, Shinnar S, Hauser WA, et al. A prospective study of recurrent febrile seizures. N Engl J Med 1992; 327:1122.</a></li><li><a class="nounderline abstract_t">Pavlidou E, Tzitiridou M, Kontopoulos E, Panteliadis CP. Which factors determine febrile seizure recurrence? A prospective study. Brain Dev 2008; 30:7.</a></li><li><a class="nounderline abstract_t">Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 1978; 61:720.</a></li><li><a class="nounderline abstract_t">Wilmshurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia 2015; 56:1185.</a></li><li><a class="nounderline abstract_t">Berg AT, Darefsky AS, Holford TR, Shinnar S. Seizures with fever after unprovoked seizures: an analysis in children followed from the time of a first febrile seizure. Epilepsia 1998; 39:77.</a></li><li><a class="nounderline abstract_t">Knudsen FU. Febrile seizures: treatment and prognosis. Epilepsia 2000; 41:2.</a></li><li><a class="nounderline abstract_t">de Haan GJ, van der Geest P, Doelman G, et al. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 2010; 51:478.</a></li><li><a class="nounderline abstract_t">Hesdorffer DC, Shinnar S, Lax DN, et al. Risk factors for subsequent febrile seizures in the FEBSTAT study. Epilepsia 2016; 57:1042.</a></li><li><a class="nounderline abstract_t">Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics 2008; 121:1281.</a></li><li><a class="nounderline abstract_t">Offringa M, Newton R, Cozijnsen MA, Nevitt SJ. Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev 2017; 2:CD003031.</a></li><li><a class="nounderline abstract_t">Natsume J, Hamano SI, Iyoda K, et al. New guidelines for management of febrile seizures in Japan. Brain Dev 2017; 39:2.</a></li><li><a class="nounderline abstract_t">Offringa M, Newton R, Nevitt SJ, Vraka K. Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev 2021; 6:CD003031.</a></li><li><a class="nounderline abstract_t">Hirabayashi Y, Okumura A, Kondo T, et al. Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness. Brain Dev 2009; 31:414.</a></li><li><a class="nounderline abstract_t">Verrotti A, Latini G, di Corcia G, et al. Intermittent oral diazepam prophylaxis in febrile convulsions: its effectiveness for febrile seizure recurrence. Eur J Paediatr Neurol 2004; 8:131.</a></li><li><a class="nounderline abstract_t">Lux AL. Treatment of febrile seizures: historical perspective, current opinions, and potential future directions. Brain Dev 2010; 32:42.</a></li><li><a class="nounderline abstract_t">Nordli DR Jr, Moshé SL, Shinnar S, et al. Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study. Neurology 2012; 79:2180.</a></li><li><a class="nounderline abstract_t">Shinnar S, Bello JA, Chan S, et al. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012; 79:871.</a></li><li><a class="nounderline abstract_t">Murata S, Okasora K, Tanabe T, et al. Acetaminophen and Febrile Seizure Recurrences During the Same Fever Episode. Pediatrics 2018; 142.</a></li><li><a class="nounderline abstract_t">Rosenbloom E, Finkelstein Y, Adams-Webber T, Kozer E. Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis. Eur J Paediatr Neurol 2013; 17:585.</a></li><li class="breakAll">Millichap JG. Febrile Convulsions, Macmillan, New York 1968.</li><li class="breakAll">Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics, 2nd, The Macmillan Company, New York 1955. p.283.</li><li><a class="nounderline abstract_t">Vestergaard M, Pedersen MG, Ostergaard JR, et al. Death in children with febrile seizures: a population-based cohort study. Lancet 2008; 372:457.</a></li><li><a class="nounderline abstract_t">Holm IA, Poduri A, Crandall L, et al. Inheritance of febrile seizures in sudden unexplained death in toddlers. Pediatr Neurol 2012; 46:235.</a></li><li><a class="nounderline abstract_t">Leaffer EB, Hinton VJ, Hesdorffer DC. Longitudinal assessment of skill development in children with first febrile seizure. Epilepsy Behav 2013; 28:83.</a></li><li><a class="nounderline abstract_t">Martinos MM, Yoong M, Patil S, et al. Recognition memory is impaired in children after prolonged febrile seizures. Brain 2012; 135:3153.</a></li><li><a class="nounderline abstract_t">Verity CM, Greenwood R, Golding J. Long-term intellectual and behavioral outcomes of children with febrile convulsions. N Engl J Med 1998; 338:1723.</a></li><li><a class="nounderline abstract_t">Nørgaard M, Ehrenstein V, Mahon BE, et al. Febrile seizures and cognitive function in young adult life: a prevalence study in Danish conscripts. J Pediatr 2009; 155:404.</a></li><li><a class="nounderline abstract_t">Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med 1976; 295:1029.</a></li><li><a class="nounderline abstract_t">Annegers JF, Hauser WA, Shirts SB, Kurland LT. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med 1987; 316:493.</a></li><li><a class="nounderline abstract_t">Vestergaard M, Pedersen CB, Sidenius P, et al. The long-term risk of epilepsy after febrile seizures in susceptible subgroups. Am J Epidemiol 2007; 165:911.</a></li><li><a class="nounderline abstract_t">Neligan A, Bell GS, Giavasi C, et al. Long-term risk of developing epilepsy after febrile seizures: a prospective cohort study. Neurology 2012; 78:1166.</a></li><li><a class="nounderline abstract_t">Pavlidou E, Panteliadis C. Prognostic factors for subsequent epilepsy in children with febrile seizures. Epilepsia 2013; 54:2101.</a></li><li><a class="nounderline abstract_t">Wo SB, Lee JH, Lee YJ, et al. Risk for developing epilepsy and epileptiform discharges on EEG in patients with febrile seizures. Brain Dev 2013; 35:307.</a></li><li><a class="nounderline abstract_t">Harini C, Nagarajan E, Kimia AA, et al. Utility of initial EEG in first complex febrile seizure. Epilepsy Behav 2015; 52:200.</a></li><li><a class="nounderline abstract_t">Choudhari PR, Lowden A, Dolce A. Exploring the Age-Old Question: What Is the Predictive Value of EEG for Future Epilepsy in Children With Complex Febrile Seizures? J Child Neurol 2023; 38:290.</a></li><li><a class="nounderline abstract_t">MILLICHAP JG, MADSEN JA, ALEDORT LM. Studies in febrile seizures. V. Clinical and electroencephalographic study in unselected patients. Neurology 1960; 10:643.</a></li><li><a class="nounderline abstract_t">Jeong KA, Han MH, Lee EH, Chung S. Early postictal electroencephalography and correlation with clinical findings in children with febrile seizures. Korean J Pediatr 2013; 56:534.</a></li><li><a class="nounderline abstract_t">Kanemura H, Mizorogi S, Aoyagi K, et al. EEG characteristics predict subsequent epilepsy in children with febrile seizure. Brain Dev 2012; 34:302.</a></li><li><a class="nounderline abstract_t">Berg AT, Shinnar S, Levy SR, Testa FM. Childhood-onset epilepsy with and without preceding febrile seizures. Neurology 1999; 53:1742.</a></li><li><a class="nounderline abstract_t">Barr WB, Ashtari M, Schaul N. Bilateral reductions in hippocampal volume in adults with epilepsy and a history of febrile seizures. J Neurol Neurosurg Psychiatry 1997; 63:461.</a></li><li><a class="nounderline abstract_t">Theodore WH, Bhatia S, Hatta J, et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology 1999; 52:132.</a></li><li><a class="nounderline abstract_t">Tanabe T, Hara K, Shimakawa S, et al. Hippocampal damage after prolonged febrile seizure: one case in a consecutive prospective series. Epilepsia 2011; 52:837.</a></li><li><a class="nounderline abstract_t">Fernández G, Effenberger O, Vinz B, et al. Hippocampal malformation as a cause of familial febrile convulsions and subsequent hippocampal sclerosis. Neurology 1998; 50:909.</a></li><li><a class="nounderline abstract_t">VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998; 43:413.</a></li><li><a class="nounderline abstract_t">Scott RC, King MD, Gadian DG, et al. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003; 126:2551.</a></li><li><a class="nounderline abstract_t">Provenzale JM, Barboriak DP, VanLandingham K, et al. Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis. AJR Am J Roentgenol 2008; 190:976.</a></li><li><a class="nounderline abstract_t">Auer T, Barsi P, Bone B, et al. History of simple febrile seizures is associated with hippocampal abnormalities in adults. Epilepsia 2008; 49:1562.</a></li><li><a class="nounderline abstract_t">Hamati-Haddad A, Abou-Khalil B. Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions. Neurology 1998; 50:917.</a></li><li><a class="nounderline abstract_t">Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol 2014; 75:178.</a></li><li><a class="nounderline abstract_t">Maytal J, Shinnar S. Febrile status epilepticus. Pediatrics 1990; 86:611.</a></li><li><a class="nounderline abstract_t">Nordli DR, Moshé SL, Shinnar S. The role of EEG in febrile status epilepticus (FSE). Brain Dev 2010; 32:37.</a></li></ol></div><div id="topicVersionRevision">Topic 96573 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29320603" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24756515" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24502379" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Emergency management of febrile status epilepticus: results of the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18525033" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Phenomenology of prolonged febrile seizures: results of the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23551165" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prolonged febrile seizures, clinical characteristics, and acute management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22335736" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Intramuscular versus intravenous therapy for prehospital status epilepticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17784533" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Childhood convulsive status epilepticus: epidemiology, management and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20692877" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Definition of the postictal state: when does it start and end?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25062294" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Rate of and risk factors for early recurrence in patients with febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9111436" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Predictors of recurrent febrile seizures. A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8151472" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4170214" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Longitudinal EEG and clinical study of children with febrile convulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1528207" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A prospective study of recurrent febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17590300" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Which factors determine febrile seizure recurrence? A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/662510" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prognosis in children with febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26122601" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9578016" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Seizures with fever after unprovoked seizures: an analysis in children followed from the time of a first febrile seizure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10643916" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Febrile seizures: treatment and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19817813" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27265870" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Risk factors for subsequent febrile seizures in the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18519501" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28225210" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prophylactic drug management for febrile seizures in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27613077" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : New guidelines for management of febrile seizures in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34131913" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prophylactic drug management for febrile seizures in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18774250" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15120684" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Intermittent oral diazepam prophylaxis in febrile convulsions: its effectiveness for febrile seizure recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19854599" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Treatment of febrile seizures: historical perspective, current opinions, and potential future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23136262" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22843278" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30297499" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acetaminophen and Febrile Seizure Recurrences During the Same Fever Episode.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23702315" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23702315" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23702315" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18692714" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Death in children with febrile seizures: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22490769" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Inheritance of febrile seizures in sudden unexplained death in toddlers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23669493" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Longitudinal assessment of skill development in children with first febrile seizure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22945967" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Recognition memory is impaired in children after prolonged febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9624192" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Long-term intellectual and behavioral outcomes of children with febrile convulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19555964" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Febrile seizures and cognitive function in young adult life: a prevalence study in Danish conscripts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/972656" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Predictors of epilepsy in children who have experienced febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3807992" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Factors prognostic of unprovoked seizures after febrile convulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17267419" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The long-term risk of epilepsy after febrile seizures in susceptible subgroups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22459683" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Long-term risk of developing epilepsy after febrile seizures: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24304433" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prognostic factors for subsequent epilepsy in children with febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22892190" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk for developing epilepsy and epileptiform discharges on EEG in patients with febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26448592" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Utility of initial EEG in first complex febrile seizure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37151049" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Exploring the Age-Old Question: What Is the Predictive Value of EEG for Future Epilepsy in Children With Complex Febrile Seizures?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14422602" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Studies in febrile seizures. V. Clinical and electroencephalographic study in unselected patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24416049" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Early postictal electroencephalography and correlation with clinical findings in children with febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21959126" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : EEG characteristics predict subsequent epilepsy in children with febrile seizure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10563622" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Childhood-onset epilepsy with and without preceding febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9343124" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Bilateral reductions in hippocampal volume in adults with epilepsy and a history of febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9921860" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21463269" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Hippocampal damage after prolonged febrile seizure: one case in a consecutive prospective series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9566371" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Hippocampal malformation as a cause of familial febrile convulsions and subsequent hippocampal sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9546321" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12937081" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18356445" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18503555" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : History of simple febrile seizures is associated with hippocampal abnormalities in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9566372" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24318290" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2216628" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Febrile status epilepticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19864096" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The role of EEG in febrile status epilepticus (FSE).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
